Profile for DexCom Inc. (DXCM)

$ 283.96   -10.09 (-3.43%) Volume: 1.12m 4:00 PM EST 25-Feb-2020
After Hours:  $ 285.00   1.04 (+0.37%) Volume: 12.89k 7:56 PM EST 25-Feb-2020
Business Description:
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
Address: 6340 Sequence Drive, San Diego, CA, USA, 92121
Telephone: +1 858 200-0200 Website:
Facsimile: N/A Email: [email protected]
CEO: Kevin R. Sayer
Employees: 3,900 Market Cap: 26.01b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1093557
Industry: Medical Diagnostics & Research
Sub-Industry:    Diagnostics & Research
NAICS: Medical Laboratories (621511)
SIC: Surgical And Medical Instruments And Apparatus (3841)